Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Bridge Biotherapeutics and HitGen Initiate Research Collaboration to Advance Novel Cancer Therapeutics Program 2024-08-22 21:30
Evolving DNA-Encoded Library Technology and Its Application for Innovative Drug Discovery, Upcoming Webinar Hosted by HitGen and Xtalks 2024-07-16 23:55
Hox Therapeutics and Vernalis announce a drug discovery collaboration in oncology 2024-02-20 22:30
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2023-09-28 21:30
HitGen Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics 2023-08-10 21:30
HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research 2023-06-26 21:30
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics 2023-05-18 21:30
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery 2022-12-12 10:10
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Contera Pharma A/S announce a strategic collaboration in the field of RNA-targeting small molecules in neurology 2022-09-28 16:00
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines Inc. announce a research collaboration in the field of anti-infectives 2022-09-05 16:00
"OpenDEL®3.0 - DRUG DISCOVERY PARTNER" webinar offered by HitGen and Endpoints News coming up on Thursday 4th August 2022-08-01 22:00
LoQus23 and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2022-07-27 16:30
HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets 2022-04-06 22:30
HitGen Announces Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery 2022-03-17 22:30
HitGen has successfully completed a three-year collaboration with MTPC to discover novel hit compounds for multiple drug targets 2022-02-25 10:00
1